NSCLC tissues and cells were observed to have evidently increased PD-L1; however, this finding was reversed in response to silencing lncRNA SNHG12, and HuR knockdown reduced the mRNA level and half-life period of PD-L1. The gene discussed is ELAVL1; the disease is non-small cell lung carcinoma.